Results 1 to 10 of about 8,187 (207)

Efficacy and safety of desogestrel/ethinylestradiol 150/20 flexible extended regimen (FREEDOM 150/20) in dysmenorrhea: phase 3 study in Japan [PDF]

open access: yesF&S Reports
Objective: To evaluate the efficacy and long-term safety of a user-driven flexible extended regimen of desogestrel 150 μg/ethinylestradiol 20 μg (DSG/EE 150/20) for the treatment of primary or secondary dysmenorrhea in women from Japan.
Kaori Koga, M.D., Ph.D.   +5 more
doaj   +2 more sources

Ethinylestradiol Transfer into Breast Milk of Women Using Low-Dose Combined Hormonal Contraception Is Negligible [PDF]

open access: yesOpen Access Journal of Contraception
Lior Segev,1,2,* Avigail Ben Zimra,1,* Gideon A Weitzman,2 Naamah Bloch,1 Itay Pitussi,3 Tatiana Alkhazov,4 Natalya M Kogan,4 David Peleg,1,5 Abraham O Samson,1 Inbar Ben Shachar1,5 1Azrieli Faculty of Medicine, Bar Ilan University, Safed,
Segev L   +9 more
doaj   +2 more sources

Metabolic consequences of perinatal bisphenol A and 17α-Ethinylestradiol exposure manifest in circadian alterations of energy homeostasis in adult male mice [PDF]

open access: yesFrontiers in Endocrinology
IntroductionEnvironmental estrogenic chemicals can cross the maternal–fetal barrier and disrupt endocrine and metabolic regulation in the developing embryo/fetus.
Imre Kalló   +8 more
doaj   +2 more sources

A Systematic Review of Estrogens as Emerging Contaminants in Water: A Global Overview Study from the One Health Perspective [PDF]

open access: yesJournal of Xenobiotics
The widespread presence of estrogens in aquatic environments represents a One Health concern, as it simultaneously threatens environmental integrity, wildlife health, and human well-being.
Rhitor Lorca da Silva   +8 more
doaj   +2 more sources

Efficacy and safety of drospirenone-containing microdosage combined oral contraceptive use with starting contraception [PDF]

open access: yesГинекология, 2018
Androgen-dependent dermopathy, as well as premenstrual syndrome of varying severity in young women, can cause emotional depression, difficulties in social adaptation and even depressive disorders. The aim of the study was to study the safety and efficacy
A R Khachaturian   +2 more
doaj   +3 more sources

Role of Estrogens in Menstrual Migraine

open access: yesCells, 2022
Migraine is a major neurological disorder affecting one in nine adults worldwide with a significant impact on health care and socioeconomic systems. Migraine is more prevalent in women than in men, with 17% of all women meeting the diagnostic criteria ...
Rossella E. Nappi   +5 more
doaj   +1 more source

Systemic hormonal contraception and risk of venous thromboembolism

open access: yesActa Obstetricia et Gynecologica Scandinavica, 2022
Introduction The increased risk of venous thromboembolism associated with the use of hormonal contraception is well recognized, but evidence regarding hormonal contraception containing natural estradiol is limited.
Oskari Heikinheimo   +5 more
doaj   +1 more source

Efficacy of cyclic and extended regimens of ethinylestradiol 0.02 mg ‐levonorgestrel 0.09 mg for dysmenorrhea: A placebo‐controlled, double‐blind, randomized trial

open access: yesReproductive Medicine and Biology, 2021
Purpose We aimed to evaluate the efficacy and safety of 28‐day Cyclic and 84‐day Extended regimens of NPC‐16 (ethinylestradiol 0.02 mg plus levonorgestrel 0.09 mg) in patients with dysmenorrhea.
Tasuku Harada, Mikio Momoeda
doaj   +1 more source

The use of Dimia for the treatment of premenstrual syndrome in adolescent girls [PDF]

open access: yesГинекология, 2019
Today, premenstrual syndrome (PMS) remains one of the relevant issues of adolescent gynecology. The difficulty in treatment of PMS in adolescent girls is associated with a large number of factors. The combination of hormonal, neuro-vegetative, metabolic,
Elena V Sibirskaya, Gulnoza M Turgunova
doaj   +1 more source

Effect of Norelgestromin and Ethinylestradiol in Transdermal Patches on the Clinical Outcomes and Biochemical Parameters of COVID-19 Patients: A Clinical Trial Pilot Study

open access: yesPharmaceuticals, 2022
The disease caused by SARS-CoV-2 is still considered a global pandemic. Transdermal patches (TP) with immunoregulators such as estrogen and progesterone compounds could be a feasible option to treat COVID-19 because of their accessibility and relative ...
Cortés-Algara Alfredo   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy